FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2410363728> ?p ?o ?g. }

• W2410363728 abstract "The GetGoal-L-Asia and -S trials were multi-center trials conducted in 4 and 16 countries, respectively including Japan that evaluated the efficacy and safety of lixisenatide add-on treatment vs. placebo among patients with type 2 diabetes. The aims of this study were to determine the efficacy and safety of lixisenatide add-on treatment among Japanese patient groups. All Japanese intent-to-treat patients with baseline and endpoint HbA1c measurements were included in the meta-analyses. Subgroup analyses were carried out for patients with low (<8 %) and high (≥8 %) baseline HbA1c levels, low (<25 kg/m2) and high (≥25 kg/m2) baseline body mass index (BMI), short (<10 years) and long (≥10 years) durations of diabetes, and for those <65 and ≥65 years of age. The overall study population of Japanese type 2 diabetes patients included 143 patients (mean age: 59.0 years; 35 % female) treated with lixisenatide and 136 patients treated with placebo (mean age: 57.8 years; 32 % female). Among the subgroups, lixisenatide treatment vs. placebo was associated with greater change in HbA1c (Low HbA1c −0.80 %, p < 0.0001; High HbA1c −1.19 %, p < 0.0001; low BMI −0.88 %, p < 0.0001; high BMI −1.28 %, p < 0.0001; short diabetes duration −1.28 %, p < 0.0001; long diabetes duration −0.93 %, p < 0.0001; <65 years: −1.00 %, p < 0.0001; ≥65 years −1.24 %, p < 0.0001). Additionally, among the subgroups, lixisenatide treatment vs. placebo was associated with greater change in post-prandial glucose. For Japanese type 2 diabetes patients lixisenatide may be an efficacious and safe add-on therapy leading to improved glycemic outcomes. GetGoal-L-Asia NCT01169779 GetGoal-S NCT00713830" @default.
• W2410363728 created "2016-06-24" @default.
• W2410363728 creator A5006188126 @default.
• W2410363728 creator A5024806209 @default.
• W2410363728 creator A5041859138 @default.
• W2410363728 creator A5087983151 @default.
• W2410363728 date "2016-06-01" @default.
• W2410363728 modified "2023-10-18" @default.
• W2410363728 title "Lixisenatide improves glycemic outcomes of Japanese patients with type 2 diabetes: a meta-analysis" @default.
• W2410363728 cites W1513833217 @default.
• W2410363728 cites W1557767719 @default.
• W2410363728 cites W1584571461 @default.
• W2410363728 cites W2002757015 @default.
• W2410363728 cites W2015710074 @default.
• W2410363728 cites W2019750418 @default.
• W2410363728 cites W2027398852 @default.
• W2410363728 cites W2032558282 @default.
• W2410363728 cites W2036454215 @default.
• W2410363728 cites W2047875943 @default.
• W2410363728 cites W2060104918 @default.
• W2410363728 cites W2060896906 @default.
• W2410363728 cites W2062831962 @default.
• W2410363728 cites W2073068020 @default.
• W2410363728 cites W2077751509 @default.
• W2410363728 cites W2097132878 @default.
• W2410363728 cites W2120128459 @default.
• W2410363728 cites W2123946565 @default.
• W2410363728 cites W2135298024 @default.
• W2410363728 cites W2146827066 @default.
• W2410363728 cites W2164350518 @default.
• W2410363728 cites W2256173852 @default.
• W2410363728 cites W2267017737 @default.
• W2410363728 cites W2270869067 @default.
• W2410363728 cites W2282578582 @default.
• W2410363728 cites W46273423 @default.
• W2410363728 doi "https://doi.org/10.1186/s13098-016-0151-7" @default.
• W2410363728 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4888474" @default.
• W2410363728 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27252787" @default.
• W2410363728 hasPublicationYear "2016" @default.
• W2410363728 type Work @default.
• W2410363728 sameAs 2410363728 @default.
• W2410363728 citedByCount "6" @default.
• W2410363728 countsByYear W24103637282017 @default.
• W2410363728 countsByYear W24103637282019 @default.
• W2410363728 countsByYear W24103637282020 @default.
• W2410363728 countsByYear W24103637282021 @default.
• W2410363728 countsByYear W24103637282022 @default.
• W2410363728 crossrefType "journal-article" @default.
• W2410363728 hasAuthorship W2410363728A5006188126 @default.
• W2410363728 hasAuthorship W2410363728A5024806209 @default.
• W2410363728 hasAuthorship W2410363728A5041859138 @default.
• W2410363728 hasAuthorship W2410363728A5087983151 @default.
• W2410363728 hasBestOaLocation W24103637281 @default.
• W2410363728 hasConcept C126322002 @default.
• W2410363728 hasConcept C134018914 @default.
• W2410363728 hasConcept C142724271 @default.
• W2410363728 hasConcept C187960798 @default.
• W2410363728 hasConcept C204787440 @default.
• W2410363728 hasConcept C27081682 @default.
• W2410363728 hasConcept C2776442814 @default.
• W2410363728 hasConcept C2777180221 @default.
• W2410363728 hasConcept C2780221984 @default.
• W2410363728 hasConcept C2780473172 @default.
• W2410363728 hasConcept C2780533449 @default.
• W2410363728 hasConcept C2908647359 @default.
• W2410363728 hasConcept C555293320 @default.
• W2410363728 hasConcept C71924100 @default.
• W2410363728 hasConcept C95190672 @default.
• W2410363728 hasConcept C99454951 @default.
• W2410363728 hasConceptScore W2410363728C126322002 @default.
• W2410363728 hasConceptScore W2410363728C134018914 @default.
• W2410363728 hasConceptScore W2410363728C142724271 @default.
• W2410363728 hasConceptScore W2410363728C187960798 @default.
• W2410363728 hasConceptScore W2410363728C204787440 @default.
• W2410363728 hasConceptScore W2410363728C27081682 @default.
• W2410363728 hasConceptScore W2410363728C2776442814 @default.
• W2410363728 hasConceptScore W2410363728C2777180221 @default.
• W2410363728 hasConceptScore W2410363728C2780221984 @default.
• W2410363728 hasConceptScore W2410363728C2780473172 @default.
• W2410363728 hasConceptScore W2410363728C2780533449 @default.
• W2410363728 hasConceptScore W2410363728C2908647359 @default.
• W2410363728 hasConceptScore W2410363728C555293320 @default.
• W2410363728 hasConceptScore W2410363728C71924100 @default.
• W2410363728 hasConceptScore W2410363728C95190672 @default.
• W2410363728 hasConceptScore W2410363728C99454951 @default.
• W2410363728 hasIssue "1" @default.
• W2410363728 hasLocation W24103637281 @default.
• W2410363728 hasLocation W24103637282 @default.
• W2410363728 hasLocation W24103637283 @default.
• W2410363728 hasLocation W24103637284 @default.
• W2410363728 hasOpenAccess W2410363728 @default.
• W2410363728 hasPrimaryLocation W24103637281 @default.
• W2410363728 hasRelatedWork W2015670292 @default.
• W2410363728 hasRelatedWork W2095358310 @default.
• W2410363728 hasRelatedWork W2136759091 @default.
• W2410363728 hasRelatedWork W2525551153 @default.
• W2410363728 hasRelatedWork W2762039367 @default.
• W2410363728 hasRelatedWork W2883817914 @default.
• W2410363728 hasRelatedWork W2962955968 @default.
• W2410363728 hasRelatedWork W2981534232 @default.

• next